Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, April 6, 2023
[ Thu, Apr 06th 2023
] - WOPRAI
[ Thu, Apr 06th 2023
] - WOPRAI
[ Thu, Apr 06th 2023
] - WOPRAI
[ Thu, Apr 06th 2023
] - WOPRAI
[ Thu, Apr 06th 2023
] - WOPRAI
[ Thu, Apr 06th 2023
] - WOPRAI
[ Thu, Apr 06th 2023
] - WOPRAI
[ Thu, Apr 06th 2023
] - WOPRAI
[ Thu, Apr 06th 2023
] - WOPRAI
[ Thu, Apr 06th 2023
] - WOPRAI
[ Thu, Apr 06th 2023
] - WOPRAI
[ Thu, Apr 06th 2023
] - WOPRAI
[ Thu, Apr 06th 2023
] - WOPRAI
[ Thu, Apr 06th 2023
] - WOPRAI
[ Thu, Apr 06th 2023
] - WOPRAI
[ Thu, Apr 06th 2023
] - WOPRAI
[ Thu, Apr 06th 2023
] - WOPRAI
[ Thu, Apr 06th 2023
] - WOPRAI
[ Thu, Apr 06th 2023
] - WOPRAI
[ Thu, Apr 06th 2023
] - WOPRAI
[ Thu, Apr 06th 2023
] - WOPRAI
[ Thu, Apr 06th 2023
] - WOPRAI
[ Thu, Apr 06th 2023
] - WOPRAI
Wed, April 5, 2023
[ Wed, Apr 05th 2023
] - WOPRAI
[ Wed, Apr 05th 2023
] - WOPRAI
[ Wed, Apr 05th 2023
] - WOPRAI
[ Wed, Apr 05th 2023
] - WOPRAI
Asthika Goonewardene Initiated (TIL) at Hold and Held Target at $120 on, Apr 5th, 2023
Asthika Goonewardene of Truist Securities, Initiated "Instil Bio, Inc." (TIL) at Hold and Held Target at $120 on, Apr 5th, 2023.
Asthika has made no other calls on TIL in the last 4 months.
There is 1 other peer that has a rating on TIL. Out of the 1 peers that are also analyzing TIL, all agrees with Asthika's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Vikram Purohit of "Morgan Stanley" Maintained at Hold with Decreased Target to $40 on, Monday, December 12th, 2022
